Biogen Idec

Biogen is a global biotechnology company, founded in 1978, with over $10B in revenue in 2022. Biogen Idec is a global leader in the discovery, development, manufacturing and commercialization of innovative therapies for various health issues such as multiple sclerosis (MS), lymphoma and rheumatoid arthritis. Biogen has multiple distributors globally that sells and distributes their drugs in 90 countries. Biogen, a true pioneer in the critical field of neuroscience, works toward solutions for conditions like multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral...